PSA final revision Flashcards
nitrofurantoin
avoid if eGFR<45
eGFR 30-44 short course for uncomplicated LUT infection with multi-drug resistance
pulmonary disease as sfx
Citalopram
Hyponatraemia
Increased bleeding with dabigatran
omeprazole increases exposure
Serotonin syndrome
ACEi and Cr
Cr rise of <20% expected
COPD exarcebation
Ipatropium bromide 500 mcg/ salbutamol 2.5mg/2.5ml nebs
Renal impairment
hold allopurinol>aspirin
Statin
> 40% in non-HDL
Common confusion causing drugs
Opioids, bentos, trazadone
Beta blockers
CI in PVD, ACEi cautioned
Methotrexate monitoring
LFTS, UES, FBC (liver toxicity, pulmonary fibrosis)
Simvastatin + gemofemobrizil
risk of myopathy
Macrolides
TDP
Ondansetron
avoid if QTc prolonged
ciclosporin
Hyperkalaemia and renal- every 2 weeks for 3 months then monthly
naproxen
ankle oedema
GLP1 analogue (sema/liraglutide)
vomiting sfx
oxycodone
good for renal impairment as metabolised by liver
fentanyl
not for acute pain
tramadol
can reduce the seizure threshold
SSRIs- serotonin syndrome
Insulin
oedema
0.1units/kg/hr
NSAIDs
avoid in HTN- fluid retention
CI in asthma
CI in VZV- necrotising fasciitis
gingival hyperplasia
ciclosporin + nifedipine (CCBs), phenytoin, mycophenylate
digoxin
dig + cholecalciferol–> dig toxicity (ECG + dig level)
rate control in AF for sedentary pt
aspirin and sulfasalazine
cross sensitivity
LMWH
CI in thrombocytopenia
doxy + isotretonoin
Benign intracranial hypertension so CI
GCA
Methylpred sodium succinate 1g injection IV for 3 days
Tremor
haloperidol + antipsychotics
salbutamol
theophylline
Gout causing drugs
aspirin, ticagrelol, diuretics, calcineurin, ciclospoirin, pyrazinamide, tacrolimus
sulfonyurea (gliclazide)
wt gain